Malaysia Cardiovascular Devices Market was valued at USD 4.14 billion in 2024 and is expected to reach USD 5.84 billion by 2030 with a CAGR of 5.90% during the forecast period.

Check out Market Research Intellect's report_name, valued at current_value in 2024, with a projected growth to forecast_value by 2033 at a CAGR of cagr_value (2026-2033).

The adoption of medical device packaging in Southeast Asia is expected to grow at a CAGR of 5.6%. The medical device packaging space is projected to increase from US$ 2,022 million in 2023 to US$ 3,477 million by 2033. Southeast Asia's medical device packaging sales were valued at US$ 1,911 million in 2022, and are anticipated to exhibit Y-o-Y growth of 5.6% in 2023.

Country wise Insight

Category-wise Insights

Scope of Report

Malaysia Ventilator Market growth can be attributed to the increasing instances of respiratory diseases and increasing number of old age population that is affected majorly by respiratory failures. Ventilator Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2027 By Equipment Type, By Product Type, By Mobility, By Mode, By Source, By End User, By Region, Competition Forecast & Opportunities, 2027

The global peripheral vascular devices market is expected to enjoy a valuation of US$ 4.7 Billion by the end of the year 2022, and further expand at a CAGR of 6.6% to reach a valuation of US$ 8.9 Billion by the year 2032. According to a recent study by Future Market Insights, peripheral vascular stents are leading the market with a share of about 78.5% in the year 2021, within the global market.

Report Scope as per Peripheral Vascular Devices Industry Analysis

Get key insights from Market Research Intellect's report_name, valued at current_value in 2024, and forecast to grow to forecast_value by 2033, with a CAGR of cagr_value (2026-2033).

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Malaysia”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Malaysia. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Malaysia. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.
The Malaysian pharmaceutical market is one of the major markets in the South East Asian region. It was valued at $1.55B in 2010, which increased to $3.46 in 2013. However, since 2015 it decreased to reach an estimated $1.94B in 2018. The decline was due to the launch of several generic drugs in the market along with the depreciation of the Malaysian Ringgit against the US Dollar. However, rising income, demographic changes and high incidence of non-communicable diseases (NCDs) are expected to drive the market in the future. The Malaysian medical device market was worth $1.28B in 2015, which increased to $1.55B in 2018. It is expected to grow at a CAGR of 9.5% from $1.74B in 2019 to $2.28B in 2022 Read More

According to Cognitive Market Research, the global Used and Refurbished Medical Imaging Equipments market size will be USD XX million in 2025. It will expand at a compound annual growth rate (CAGR) of XX% from 2025 to 2033.

North America held the major market share for more than XX% of the global revenue with a market size of USD XX million in 2025 and will grow at a CAGR of XX% from 2025 to 2033.
Europe accounted for a market share of over XX% of the global revenue with a market size of USD XX million in 2025 and will grow at a CAGR of XX% from 2025 to 2033.
Asia Pacific held a market share of around XX% of the global revenue with a market size of USD XX million in 2025 and will grow at a CAGR of XX% from 2025 to 2033.
Latin America had a market share of more than XX% of the global revenue with a market size of USD XX million in 2025 and will grow at a CAGR of XX% from 2025 to 2033.
Middle East and Africa had a market share of around XX% of the global revenue and was estimated at a market size of USD XX million in 2025 and will grow at a CAGR of XX% from 2025 to 2033.

Market Drivers

Rising Demand for Affordable Diagnostics Drives Market Growth

One of the primary drivers of the used and refurbished imaging equipment market is the growing need for affordable diagnostic solutions in low- and middle-income countries. As the global burden of non-communicable diseases (NCDs) such as cancer, cardiovascular disease, and neurological disorders continues to rise, access to imaging becomes essential for timely detection and intervention. However, the high cost of new MRI or CT systems often acts as a barrier, especially for small clinics and private hospitals in emerging regions. (Source: Availability of essential diagnostics in ten low-income and middle-income countries: results from national health facility surveys - The Lancet Global Health) Refurbished systems offer a viable alternative, enabling healthcare providers to access modern imaging technologies without compromising on quality. Certified vendors often provide comprehensive overhauls, warranty coverage, and installation support, making these systems operationally reliable. For example, organizations such as WHO and UNICEF have endorsed refurbished equipment procurement in resource-limited settings as part of broader efforts to expand diagnostic capacity in Africa and South Asia. (Source: Methods for medical device and equipment procurement and prioritization within low- and middle-income countries: findings of a systematic literature review - PMC)

Sustainability and Circular Economy Trends Support Market Expansion

The shift toward environmental sustainability in the healthcare sector is further accelerating the demand for refurbished medical imaging equipment. Hospitals and health systems are increasingly adopting circular economy models, which prioritize equipment reuse, refurbishment, and lifecycle extension to reduce environmental impact. This approach aligns with broader ESG (Environmental, Social, and Governance) goals adopted by healthcare institutions worldwide. Manufacturers and third-party vendors have responded by creating dedicated refurbishment programs with ISO 13485 certification and FDA/CE compliance. These programs ensure that equipment undergoes rigorous quality control, software upgrades, and performance validation. As environmental regulations become stricter and public procurement policies evolve, refurbished medical devices are gaining wider acceptance in both public and private healthcare systems.

Restraint

Regulatory Complexity and Stigma around Used Equipment Limit Market Growth

Despite growing acceptance, the used and refurbished imaging equipment market faces challenges related to regulatory inconsistency and lingering perceptions about quality. Regulatory frameworks governing the sale of refurbished medical equipment vary significantly across regions. While the EU and U.S. have well-established pathways for certified refurbishment, several countries in Latin America, Africa, and Southeast Asia lack standardized protocols, leading to market fragmentation and import restrictions. (Source: Full article: Regulatory landscape, risks, and solutions for refurbished medical devices: a comparative analysis in the US, EU, Malaysia, and Ghana) In addition, there remains a psychological barrier among some healthcare providers who view used equipment as inferior or less reliable. This stigma ...

Learn more about Market Research Intellect's report_name, valued at current_value in 2024, and set to grow to forecast_value by 2033 with a CAGR of cagr_value (2026-2033).

The Southeast Asia Diabetes Devices Market is projected to grow from USD 2.09 billion in 2025 to USD 5.61 billion by 2033, exhibiting a CAGR of 9.36% during the forecast period. The increasing prevalence of diabetes, rising healthcare expenditure, and technological advancements in diabetes management devices are key factors driving market growth. The rising geriatric population, growing awareness about diabetes, and increasing urbanization also contribute to the market's expansion. The market is segmented by type, distribution channel, end use, country, and company. By type, the insulin delivery devices segment dominates the market, owing to the increasing adoption of insulin pumps and pens for effective diabetes management. The continuous glucose monitoring devices segment is expected to witness significant growth due to the rising demand for real-time glucose monitoring. By distribution channel, the hospital pharmacies segment holds the largest market share due to the availability of a wide range of devices and the presence of healthcare professionals to guide patients. The online pharmacies segment is anticipated to grow rapidly due to the convenience and affordability of purchasing diabetes devices online. This report provides a comprehensive analysis of the Southeast Asia Diabetes Devices Market, offering valuable insights into market size, trends, competitive landscapes, and future prospects. Recent developments include: In February 2024, Duopharma Biotech Berhad partnered with Owen Mumford Sdn Bhd, a UK-based medical device manufacturer Owen Mumford subsidiary, to distribute a range of diabetes care products in Brunei, Malaysia, and Singapore. The partnership aims to provide better access to medical devices for needy patients, particularly those with diabetes , In April 2022, Gan & Lee Pharmaceuticals, a leading pharmaceutical company, announced the approval of its insulin pen in Thailand. This approval marks a significant milestone for the company as it expands its presence in the Southeast Asian market. The insulin pen is a crucial medical device for individuals with diabetes, allowing for convenient and accurate insulin delivery , In April 2021, Dexcom, a prominent U.S.-based diabetes care technology provider, planned to establish a significant manufacturing presence in Malaysia. The company intends to construct a sprawling 1.8 million square feet manufacturing facility in the country, marking its first foray into establishing a production site in Asia. Dexcom’s decision to expand its operations into Malaysia underscores its strategic vision to enhance its global footprint and cater to the growing demand for innovative diabetes management solutions in the region .

Malaysia Diabetes Care Devices Market size was valued at $59.83 Mn in 2024 & is projected to reach $ 117.74 Mn by 2032, growing at a CAGR of 8.83% from 2026-2032.Key Market DriversGovernment Healthcare Initiatives and Support: The Malaysian government's strong commitment to diabetes management is driving market expansion with significant healthcare investments and smart initiatives. The Ministry of Health allocated RM 31.9 billion (USD 7.2 billion) for 2022, with a large amount going toward addressing noncommunicable diseases like as diabetes. The 2016-2025 National Strategic Plan for Noncommunicable Diseases (NSP-NCD) emphasizes improved screening and management, as well as the development of infrastructure for diabetic care devices. These activities increase accessibility, encourage early diagnosis, and support technical improvements, ultimately increasing the use of diabetes care devices across the country.Increasing Focus on Home-Based Monitoring: The growing trend toward home-based diabetes monitoring is expanding the market, owing to greater self-monitoring of blood glucose (SMBG), which increased by 27% between 2018 and 2022, according to MEMS. The COVID-19 pandemic expedited this trend, with a 35% increase in telemedicine consultations for diabetes care in 2020-2021, according to the Ministry of Health Malaysia. This shift improves patient comfort, lowers hospital visits, and encourages early intervention, resulting in increased use of home-based monitoring devices for better diabetes care.

Malaysia Robotics Market size was valued at USD 129.2 Billion in 2024 and is projected to reach USD 419.62 Billion by 2031, growing at a CAGR of 17.50% during the forecast period 2024-2031.Malaysia Robotics Market DriversGovernment Initiatives: With programs like the National Policy on Industry 4.0 (Industry4WRD), the Malaysian government has been aggressively encouraging the use of robots and automation in a variety of industries. These programs encourage businesses to invest in robotics technology by offering incentives and support.Adoption of Industry 4.0: To improve manufacturing productivity and competitiveness, Malaysia is using Industry 4.0 concepts. Automation and smart manufacturing depend heavily on robotics, which helps businesses increase productivity, cut expenses, and enhance quality.

In 2023, the amount of instruments used in medical sciences exported from Malaysia skyrocketed to 11K tons, picking up by 16% on the year before.

Malaysia Advanced Wound Care Market size was valued at USD 1.6 Billion in 2023 and is projected to reach USD 2.5 Billion by 2030, growing at a CAGR of 7.5% during the forecast period 2024-2030.

Malaysia Advanced Wound Care Market Drivers

The market drivers for the Malaysia Advanced Wound Care Market can be influenced by various factors. These may include:

Growing Prevalence of Chronic Wounds: In Malaysia, the need for advanced wound care products is driven by the growing prevalence of chronic wounds, including pressure ulcers, venous leg ulcers, and diabetic foot ulcers. The prevalence of diabetes, lifestyle disorders, and an aging population are some of the factors that add to the rising cost of chronic wounds.

Growing Geriatric Population: Malaysia is going through demographic changes, similar to many other nations, with a growing percentage of its population becoming aged. The need for sophisticated wound care products and services is being driven by the higher prevalence of chronic diseases and other ailments in older populations, which can result in non-healing wounds.

Technological Developments in Wound Care: The creation of sophisticated dressings, negative pressure wound therapy (NPWT), and bioengineered skin substitutes are just a few examples of the ongoing technological developments in wound care that are fueling the expansion of the advanced wound care market in Malaysia. These advancements provide quicker healing times, better patient comfort, and better healing results.

Government programs and Healthcare Investments: The development of Malaysia's advanced wound care market is largely due to government programs that improve access to sophisticated medical treatments and the infrastructure supporting healthcare. The growth of the market is aided by investments in medical facilities, professional training courses, and medical device subsidies.

Growing Knowledge about Wound treatment: The availability of cutting-edge wound care solutions and the growing understanding of the value of appropriate wound treatment among patients and healthcare professionals both support market expansion. Adoption of advanced wound care products is encouraged and awareness raised by educational programs, seminars, and campaigns centered around best practices in wound care.

Growing Healthcare Expenditure: The adoption of sophisticated wound care products and services is supported by Malaysia's growing healthcare expenditure, which is fueled by the country's economic growth, rising earnings, and expanding insurance coverage. In order to improve clinical results and quality of life, patients and healthcare professionals are becoming more and more eager to invest in cutting-edge wound care treatments.

High Diabetes Incidence: Diabetes is a major risk factor for chronic wounds like diabetic foot ulcers, and it is notably prevalent in Malaysia. The need for sophisticated wound care solutions specifically designed to manage diabetic wounds is growing as the prevalence of diabetes rises as a result of shifting dietary and lifestyle patterns.

Expansion of Home Healthcare Services: There are prospects for the adoption of cutting-edge wound care products that are appropriate for use in home settings due to the growing trend towards home-based healthcare services, including wound care management. Solutions that allow for more comfort and convenience at home and promote efficient wound healing are sought after by patients and caregivers.

Malaysia Medical Refrigerator Market size was valued at USD 32.5 Million in 2024 and is projected to reach USD 61.8 Million by 2032, growing at a CAGR of 8.4% during the forecast period 2026-2032.The Malaysia medical refrigerator market is experiencing steady growth, driven by several key factors. The expansion of healthcare infrastructure, including the construction of new hospitals and clinics, has increased the demand for reliable cold storage solutions to preserve vaccines, blood products, and pharmaceuticals. Government initiatives aimed at improving healthcare access, particularly in rural areas, have led to the procurement of medical refrigeration equipment to support immunization programs and disaster preparedness efforts . The rising prevalence of chronic diseases and the growing emphasis on personalized medicine have further necessitated the use of specialized refrigeration units to store temperature-sensitive biological samples and advanced therapies . Technological advancements have resulted in the development of energy-efficient and smart medical refrigerators, enhancing temperature control and monitoring capabilities. Additionally, the increasing focus on medical tourism has prompted private healthcare facilities to invest in high-quality refrigeration systems to meet international standards and attract foreign patients . Collectively, these factors are propelling the growth of the medical refrigerator market in Malaysia.

Market Size for Malaysia Dairy Food Products Industry on the Basis of Revenues in USD Billion, 2018-2024 In 2023, Dutch Lady Milk Industries launched a new line of fortified dairy beverages to cater to the health-conscious segment of the market. This initiative aims to tap into the growing demand for functional foods in Malaysia, offering products that provide additional health benefits beyond basic nutrition. Kuala Lumpur and Johor are key markets due to their high population density and strong retail infrastructure. The Malaysia dairy food products market reached a valuation of MYR 5.5 Billion in 2023, driven by the increasing demand for healthy and convenient food options, rising health awareness, and a growing population with a preference for dairy-based products. The market is characterized by major players such as Fonterra, Nestlé Malaysia, Dutch Lady Milk Industries, and Marigold. These companies are recognized for their extensive distribution networks, diverse product offerings, and customer-focused marketing strategies.

Snapshot img

What is the Size of Tongkat Ali Products Market?

The tongkat ali products market size is forecast to increase by USD 93.1 million, CAGR of 5.8% between 2023 and 2028. The market is experiencing significant growth due to the increasing recognition of its health benefits. This natural herbal extract, native to Southeast Asia, is known for its potential to improve blood flow, alleviate symptoms of diarrhea and dysentery, and act as a folk remedy for intestinal worms. Additionally, Tongkat Ali has gained popularity in addressing male health issues such as erectile dysfunction and stress. Its potential applications extend to treating conditions like leukemia, osteoporosis, syphilis, glandular swelling, and malaria. However, it's essential to note that while the benefits are promising, potential side effects include agitation, insomnia, and increased heart rate. As research and development efforts continue, the market is expected to expand, providing new opportunities for businesses and consumers alike.

Request Free Tongkat Ali Products Market Sample

Market Segmentation

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.

Application

  Pharmaceuticals
  Dietary supplements
  Cosmetics and personal care


Type

  Powder
  Capsules or tablets
  Liquid extract


Geography

  APAC

    South Korea
    Thailand


  North America

    Canada
    US


  Europe

    Germany
    UK
    France
    Spain


  Middle East and Africa



  South America

Which is the Largest Segment Driving Market Growth?

The pharmaceuticals segment is estimated to witness significant growth during the forecast period. Tongkat Ali, a native Malaysian herb, is gaining popularity in the dietary supplement market due to its various health benefits. This natural herb is known for its potential as an appetite stimulant, antibacterial agent, and nutritional supplement. Tongkat ali extract has emerged as a potential solution, owing to its ability to aid in weight loss and improve metabolic health. Clinical research continues to uncover tongkat Ali's impact on hormonal health, muscular strength, and stress management. Its role as a natural herbal drug has been the subject of numerous studies, revealing its potential to naturally boost testosterone levels. This effect can lead to enhanced muscle strength and endurance, making it a valuable therapeutic intervention for individuals dealing with hormonal imbalances or age-related testosterone decline. Moreover, tongkat ali's adaptogenic properties make it an attractive alternative for managing stress. As the demand for natural remedies grows, the market for tongkat ali extract is expected to expand significantly.

Get a glance at the market share of various regions Download the PDF Sample

The pharmaceuticals segment was valued at USD 92.40 million in 2018. Additionally, potential contaminants like mercury can be present in some tongkat ali products, highlighting the importance of purchasing from reputable suppliers. To ensure the highest quality and safety, it is advisable to consult a healthcare professional before incorporating tongkat ali extract into your wellness routine. In conclusion, the versatility and health benefits of tongkat ali have positioned it as a valuable addition to the nutraceutical industry. As research continues to uncover its potential applications, the demand for tongkat ali extract is expected to increase, making it a worthwhile investment for both manufacturers and consumers.

Which Region is Leading the Market?

For more insights on the market share of various regions Request Free Sample

APAC is estimated to contribute 37% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The Tongkat Ali products market in the Asia-Pacific region is experiencing notable growth due to the herb's traditional use and increasing scientific validation of its health benefits. Countries such as Malaysia, Indonesia, Thailand, and Vietnam are leading this market, utilizing their agricultural heritage of Eurycoma longifolia cultivation. Notably, Malaysia has developed proprietary extracts like Physta tongkat ali, which has gained recognition for its potential antiviral properties and benefits for healthy aging and immune support. The demand for Tongkat Ali in the Asia-Pacific region is fueled by growing consumer awareness of natural supplements and a rising interest in holistic health solutions. This herbal medicine is particularly popular for its aphrodisiac properties and potential benefits for male sexual health. The active compounds in Tongkat Ali, including quassinoids and e

The Malaysia Diabetes Care Devices market, valued at $321.71 million in 2025, is projected to experience robust growth, driven by rising diabetes prevalence, increasing awareness of advanced diabetes management, and government initiatives promoting better healthcare access. The market's Compound Annual Growth Rate (CAGR) of 4.70% from 2019 to 2024 suggests a continued upward trajectory through 2033. Key segments include monitoring devices (self-monitoring blood glucose devices like glucometers, test strips, and lancets, as well as continuous glucose monitoring systems), and management devices (insulin pumps, syringes, cartridges, and disposable pens). The increasing adoption of continuous glucose monitoring (CGM) systems, offering real-time glucose data, is a significant growth driver, along with the rising preference for convenient insulin delivery systems like insulin pumps. However, high device costs and limited healthcare insurance coverage in certain segments of the population could pose challenges. Furthermore, the market's growth is also influenced by factors such as technological advancements leading to more accurate and user-friendly devices, increased investment in diabetes research and development, and growing public-private partnerships aimed at improving diabetes care infrastructure in Malaysia. Major players like Becton Dickinson, Medtronic, Insulet, Tandem, Ypsomed, Novo Nordisk, Sanofi, Eli Lilly, Abbott, Roche, and Lifescan (Johnson & Johnson) are competing intensely to capture market share, focusing on product innovation and strategic partnerships to expand their reach. The market's segmentation provides opportunities for specialized players to target specific needs within the diabetes care spectrum. Further expansion is expected through improvements in affordability, accessibility, and targeted educational campaigns to raise awareness about diabetes management and the benefits of using these devices. The forecast period (2025-2033) presents a promising outlook for investors and stakeholders in the Malaysian diabetes care devices market, fueled by continued advancements in technology and growing patient needs. Recent developments include: June 2023: Dexcom, a San Diego-based company specializing in continuous glucose monitors, has announced its intention to release a new wearable device in 2024. This device is specifically designed for individuals with Type 2 diabetes who do not require insulin, and is expected to contribute to the growing popularity of wearable health monitors., May 2023: Medtronic plc has recently disclosed its plans to acquire EOFlow Co. Ltd., a renowned manufacturer of the EOPatch device. This innovative insulin delivery device is tubeless, wearable, and fully disposable. By incorporating EOFlow into its portfolio, Medtronic aims to enhance its capacity to cater to a larger population of individuals with diabetes. This strategic move, coupled with Medtronic's advanced Meal Detection Technology algorithm and next-generation continuous glucose monitor (CGM), is anticipated to significantly broaden the company's capabilities in meeting the diverse requirements of people living with diabetes.. Notable trends are: Management Devices Hold Highest Market Share in Malaysia Diabetes Care Devices Market.

The global orthopedic bone cement market, valued at $3.11 billion in 2025, is projected to experience robust growth, driven by a rising geriatric population susceptible to osteoarthritis and other bone-related conditions necessitating joint replacement surgeries. The market's Compound Annual Growth Rate (CAGR) of 5.68% from 2025 to 2033 indicates a significant expansion. This growth is further fueled by advancements in bone cement formulations, including the development of biocompatible and less-irritating materials like PMMA alternatives, and the increasing adoption of minimally invasive surgical techniques. The high viscosity cement segment is expected to dominate due to its superior handling characteristics during surgical procedures. Regionally, North America currently holds a substantial market share, driven by high healthcare expenditure and technological advancements. However, Asia Pacific is poised for significant growth due to rising disposable incomes, increasing healthcare awareness, and a burgeoning medical infrastructure, particularly in countries like China and India. Competition is intense, with major players such as Stryker, Smith & Nephew, and Zimmer Biomet vying for market dominance through innovation, strategic partnerships, and geographical expansion. The increasing demand for antibiotic-laden cements to minimize post-operative infections presents a significant opportunity for market expansion. Challenges, however, include the potential for cement-related complications and the ongoing search for more biocompatible and effective alternatives. The orthopedic bone cement market's segmentation by material (PMMA, ceramic, acrylic) and product type (low, medium, high viscosity; antibiotic) reflects the diverse needs of orthopedic procedures. The hospital and orthopedic clinic end-user segment accounts for the majority of market demand. Future growth hinges upon the successful development of novel biomaterials that offer superior biocompatibility, reduced inflammatory responses, and enhanced osseointegration – leading to better patient outcomes and driving increased market adoption. Furthermore, regulatory approvals for new products and technological innovations in surgical techniques will significantly impact market trajectory. Continued research and development efforts focused on minimizing complications, enhancing bone cement properties, and improving patient safety are key factors determining the market's future prospects. Recent developments include: July 2022: GRAFTYS SA, a recognized specialist in resorbable bone cement for orthopedic surgery, completed an investment round of EUR 2.0 million with its existing shareholders to accelerate the commercial development and new product launches., May 2022: KPower Bhd, a subsidiary of Granulab (M) Sdn Bhd, launched Malaysia's first halal-certified synthetic bone cement, Prosteomax. Prosteomax is an innovative synthetic calcium phosphate bone cement that has been certified as halal by the Islamic Development Department of Malaysia (Jakim) and registered with the Malaysian Medical Device Authority for orthopedic, cranio, dental, and maxillofacial uses.. Key drivers for this market are: Rising Number of Trauma and Road Accidents Cases, Increasing Number of Orthopedic, Cranial and Spine Surgery Procedures; Rising Prevalence of Osteoporosis. Potential restraints include: Rising Number of Trauma and Road Accidents Cases, Increasing Number of Orthopedic, Cranial and Spine Surgery Procedures; Rising Prevalence of Osteoporosis. Notable trends are: The Polymethyl Methacrylate, is Expected to Witness Healthy Growth Over the Forecast Period.

The Malaysia Digital Transformation Market report segments the industry into By Type (Analytics, Artificial Intelligence and Machine Learning, Extended Reality (XR), IoT, Industrial Robotics, Blockchain, and more), By End-User Industry (Manufacturing, Oil, Gas and Utilities, Retail & e-commerce, Transportation and Logistics, Healthcare, BFSI, Telecom and IT, and more).